tirzepatide injection site burning thigh: guide to proper technique and placement TrimRX | GLP-1 Injection Site

In March 2026, FDA issued 30 warning letters to telehealth companies marketing compounded GLP-1 products, citing claims that those products were equivalent or comparable to FDA-approved drugs, as well as marketing that blurred the line between approved and unapproved therapies

This model is similar to other digital health providers in the GLP-1 space

Blood Sugar Safety: A common concern with metabolic treatments is how they affect insulin

Novo Nordisk filed a brief in support of these motions, saying that the experts are not experts and that current FDA-approved labeling is adequate and protects patients

rather, it serves as a powerful tool that enables patients to adhere to a lower-calorie diet without the constant distraction of food cravings